Global Cell-Based Immunotherapy Market Research Report 2022 - Market Study Report

Global Cell-Based Immunotherapy Market Research Report 2022

Report Format: PDF   |   Report ID: 5515878   |   Published Date: August 2022   |   Pages:  103  

Choose License
Market Analysis and Insights: Global Cell-Based Immunotherapy Market
The global Cell-Based Immunotherapy market size is projected to reach US$  million by 2028, from US$  million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Autologous Cellular Immunotherapy accounting for % of the Cell-Based Immunotherapy global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Cell-Based Immunotherapy market size is valued at US$  million in 2021, while the North America and Europe Cell-Based Immunotherapy are US$  million and US$  million, severally. The proportion of the North America is  % in 2021, while China and Europe are  % and respectively, and it is predicted that China proportion will reach  % in 2028, trailing a CAGR of  % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR  %,  %, and   % respectively for the next 6-year period. As for the Europe Cell-Based Immunotherapy landscape, Germany is projected to reach US$  million by 2028 trailing a CAGR of  % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cell-Based Immunotherapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cell-Based Immunotherapy market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cell-Based Immunotherapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cell-Based Immunotherapy market.
Global Cell-Based Immunotherapy Scope and Market Size
Cell-Based Immunotherapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cell-Based Immunotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
    Autologous Cellular Immunotherapy
    Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Dendritic Cell-based Vaccine Therapy
Segment by Application
    Hospitals
    Clinics
    Ambulatory Surgical Centers
    Others
By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
By Company
    Novartis
    Gilead Sciences
    AbbVie
    Bristol-Myers Squibb
    Amgen
    AstraZeneca
    Biogen
    Boehringer Ingelheim
    Eli Lilly and Company
    GSK
    Pfizer
    Roche
    Takara Bio
    Bausch Health
    Apac Biotech
    Dendreon Pharmaceuticals (SanPower)
    JW CreaGene
    Green Cross Corp
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cell-Based Immunotherapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Autologous Cellular Immunotherapy
        1.2.3 Chimeric Antigen Receptor (CAR) T-Cell Therapy
        1.2.4 Dendritic Cell-based Vaccine Therapy
    1.3 Market by Application
        1.3.1 Global Cell-Based Immunotherapy Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Ambulatory Surgical Centers
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Cell-Based Immunotherapy Market Perspective (2017-2028)
    2.2 Cell-Based Immunotherapy Growth Trends by Region
        2.2.1 Cell-Based Immunotherapy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Cell-Based Immunotherapy Historic Market Size by Region (2017-2022)
        2.2.3 Cell-Based Immunotherapy Forecasted Market Size by Region (2023-2028)
    2.3 Cell-Based Immunotherapy Market Dynamics
        2.3.1 Cell-Based Immunotherapy Industry Trends
        2.3.2 Cell-Based Immunotherapy Market Drivers
        2.3.3 Cell-Based Immunotherapy Market Challenges
        2.3.4 Cell-Based Immunotherapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Cell-Based Immunotherapy Players by Revenue
        3.1.1 Global Top Cell-Based Immunotherapy Players by Revenue (2017-2022)
        3.1.2 Global Cell-Based Immunotherapy Revenue Market Share by Players (2017-2022)
    3.2 Global Cell-Based Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Cell-Based Immunotherapy Revenue
    3.4 Global Cell-Based Immunotherapy Market Concentration Ratio
        3.4.1 Global Cell-Based Immunotherapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cell-Based Immunotherapy Revenue in 2021
    3.5 Cell-Based Immunotherapy Key Players Head office and Area Served
    3.6 Key Players Cell-Based Immunotherapy Product Solution and Service
    3.7 Date of Enter into Cell-Based Immunotherapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Cell-Based Immunotherapy Breakdown Data by Type
    4.1 Global Cell-Based Immunotherapy Historic Market Size by Type (2017-2022)
    4.2 Global Cell-Based Immunotherapy Forecasted Market Size by Type (2023-2028)
5 Cell-Based Immunotherapy Breakdown Data by Application
    5.1 Global Cell-Based Immunotherapy Historic Market Size by Application (2017-2022)
    5.2 Global Cell-Based Immunotherapy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Cell-Based Immunotherapy Market Size (2017-2028)
    6.2 North America Cell-Based Immunotherapy Market Size by Country (2017-2022)
    6.3 North America Cell-Based Immunotherapy Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Cell-Based Immunotherapy Market Size (2017-2028)
    7.2 Europe Cell-Based Immunotherapy Market Size by Country (2017-2022)
    7.3 Europe Cell-Based Immunotherapy Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Cell-Based Immunotherapy Market Size (2017-2028)
    8.2 Asia-Pacific Cell-Based Immunotherapy Market Size by Country (2017-2022)
    8.3 Asia-Pacific Cell-Based Immunotherapy Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Cell-Based Immunotherapy Market Size (2017-2028)
    9.2 Latin America Cell-Based Immunotherapy Market Size by Country (2017-2022)
    9.3 Latin America Cell-Based Immunotherapy Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Cell-Based Immunotherapy Market Size (2017-2028)
    10.2 Middle East & Africa Cell-Based Immunotherapy Market Size by Country (2017-2022)
    10.3 Middle East & Africa Cell-Based Immunotherapy Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Novartis
        11.1.1 Novartis Company Detail
        11.1.2 Novartis Business Overview
        11.1.3 Novartis Cell-Based Immunotherapy Introduction
        11.1.4 Novartis Revenue in Cell-Based Immunotherapy Business (2017-2022)
        11.1.5 Novartis Recent Development
    11.2 Gilead Sciences
        11.2.1 Gilead Sciences Company Detail
        11.2.2 Gilead Sciences Business Overview
        11.2.3 Gilead Sciences Cell-Based Immunotherapy Introduction
        11.2.4 Gilead Sciences Revenue in Cell-Based Immunotherapy Business (2017-2022)
        11.2.5 Gilead Sciences Recent Development
    11.3 AbbVie
        11.3.1 AbbVie Company Detail
        11.3.2 AbbVie Business Overview
        11.3.3 AbbVie Cell-Based Immunotherapy Introduction
        11.3.4 AbbVie Revenue in Cell-Based Immunotherapy Business (2017-2022)
        11.3.5 AbbVie Recent Development
    11.4 Bristol-Myers Squibb
        11.4.1 Bristol-Myers Squibb Company Detail
        11.4.2 Bristol-Myers Squibb Business Overview
        11.4.3 Bristol-Myers Squibb Cell-Based Immunotherapy Introduction
        11.4.4 Bristol-Myers Squibb Revenue in Cell-Based Immunotherapy Business (2017-2022)
        11.4.5 Bristol-Myers Squibb Recent Development
    11.5 Amgen
        11.5.1 Amgen Company Detail
        11.5.2 Amgen Business Overview
        11.5.3 Amgen Cell-Based Immunotherapy Introduction
        11.5.4 Amgen Revenue in Cell-Based Immunotherapy Business (2017-2022)
        11.5.5 Amgen Recent Development
    11.6 AstraZeneca
        11.6.1 AstraZeneca Company Detail
        11.6.2 AstraZeneca Business Overview
        11.6.3 AstraZeneca Cell-Based Immunotherapy Introduction
        11.6.4 AstraZeneca Revenue in Cell-Based Immunotherapy Business (2017-2022)
        11.6.5 AstraZeneca Recent Development
    11.7 Biogen
        11.7.1 Biogen Company Detail
        11.7.2 Biogen Business Overview
        11.7.3 Biogen Cell-Based Immunotherapy Introduction
        11.7.4 Biogen Revenue in Cell-Based Immunotherapy Business (2017-2022)
        11.7.5 Biogen Recent Development
    11.8 Boehringer Ingelheim
        11.8.1 Boehringer Ingelheim Company Detail
        11.8.2 Boehringer Ingelheim Business Overview
        11.8.3 Boehringer Ingelheim Cell-Based Immunotherapy Introduction
        11.8.4 Boehringer Ingelheim Revenue in Cell-Based Immunotherapy Business (2017-2022)
        11.8.5 Boehringer Ingelheim Recent Development
    11.9 Eli Lilly and Company
        11.9.1 Eli Lilly and Company Company Detail
        11.9.2 Eli Lilly and Company Business Overview
        11.9.3 Eli Lilly and Company Cell-Based Immunotherapy Introduction
        11.9.4 Eli Lilly and Company Revenue in Cell-Based Immunotherapy Business (2017-2022)
        11.9.5 Eli Lilly and Company Recent Development
    11.10 GSK
        11.10.1 GSK Company Detail
        11.10.2 GSK Business Overview
        11.10.3 GSK Cell-Based Immunotherapy Introduction
        11.10.4 GSK Revenue in Cell-Based Immunotherapy Business (2017-2022)
        11.10.5 GSK Recent Development
    11.11 Pfizer
        11.11.1 Pfizer Company Detail
        11.11.2 Pfizer Business Overview
        11.11.3 Pfizer Cell-Based Immunotherapy Introduction
        11.11.4 Pfizer Revenue in Cell-Based Immunotherapy Business (2017-2022)
        11.11.5 Pfizer Recent Development
    11.12 Roche
        11.12.1 Roche Company Detail
        11.12.2 Roche Business Overview
        11.12.3 Roche Cell-Based Immunotherapy Introduction
        11.12.4 Roche Revenue in Cell-Based Immunotherapy Business (2017-2022)
        11.12.5 Roche Recent Development
    11.13 Takara Bio
        11.13.1 Takara Bio Company Detail
        11.13.2 Takara Bio Business Overview
        11.13.3 Takara Bio Cell-Based Immunotherapy Introduction
        11.13.4 Takara Bio Revenue in Cell-Based Immunotherapy Business (2017-2022)
        11.13.5 Takara Bio Recent Development
    11.14 Bausch Health
        11.14.1 Bausch Health Company Detail
        11.14.2 Bausch Health Business Overview
        11.14.3 Bausch Health Cell-Based Immunotherapy Introduction
        11.14.4 Bausch Health Revenue in Cell-Based Immunotherapy Business (2017-2022)
        11.14.5 Bausch Health Recent Development
    11.15 Apac Biotech
        11.15.1 Apac Biotech Company Detail
        11.15.2 Apac Biotech Business Overview
        11.15.3 Apac Biotech Cell-Based Immunotherapy Introduction
        11.15.4 Apac Biotech Revenue in Cell-Based Immunotherapy Business (2017-2022)
        11.15.5 Apac Biotech Recent Development
    11.16 Dendreon Pharmaceuticals (SanPower)
        11.16.1 Dendreon Pharmaceuticals (SanPower) Company Detail
        11.16.2 Dendreon Pharmaceuticals (SanPower) Business Overview
        11.16.3 Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Introduction
        11.16.4 Dendreon Pharmaceuticals (SanPower) Revenue in Cell-Based Immunotherapy Business (2017-2022)
        11.16.5 Dendreon Pharmaceuticals (SanPower) Recent Development
    11.17 JW CreaGene
        11.17.1 JW CreaGene Company Detail
        11.17.2 JW CreaGene Business Overview
        11.17.3 JW CreaGene Cell-Based Immunotherapy Introduction
        11.17.4 JW CreaGene Revenue in Cell-Based Immunotherapy Business (2017-2022)
        11.17.5 JW CreaGene Recent Development
    11.18 Green Cross Corp
        11.18.1 Green Cross Corp Company Detail
        11.18.2 Green Cross Corp Business Overview
        11.18.3 Green Cross Corp Cell-Based Immunotherapy Introduction
        11.18.4 Green Cross Corp Revenue in Cell-Based Immunotherapy Business (2017-2022)
        11.18.5 Green Cross Corp Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global Cell-Based Immunotherapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Autologous Cellular Immunotherapy Table 3. Key Players of Chimeric Antigen Receptor (CAR) T-Cell Therapy Table 4. Key Players of Dendritic Cell-based Vaccine Therapy Table 5. Global Cell-Based Immunotherapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Cell-Based Immunotherapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Cell-Based Immunotherapy Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Cell-Based Immunotherapy Market Share by Region (2017-2022) Table 9. Global Cell-Based Immunotherapy Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Cell-Based Immunotherapy Market Share by Region (2023-2028) Table 11. Cell-Based Immunotherapy Market Trends Table 12. Cell-Based Immunotherapy Market Drivers Table 13. Cell-Based Immunotherapy Market Challenges Table 14. Cell-Based Immunotherapy Market Restraints Table 15. Global Cell-Based Immunotherapy Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Cell-Based Immunotherapy Market Share by Players (2017-2022) Table 17. Global Top Cell-Based Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Based Immunotherapy as of 2021) Table 18. Ranking of Global Top Cell-Based Immunotherapy Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Cell-Based Immunotherapy Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Cell-Based Immunotherapy Product Solution and Service Table 22. Date of Enter into Cell-Based Immunotherapy Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Cell-Based Immunotherapy Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Cell-Based Immunotherapy Revenue Market Share by Type (2017-2022) Table 26. Global Cell-Based Immunotherapy Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Cell-Based Immunotherapy Revenue Market Share by Type (2023-2028) Table 28. Global Cell-Based Immunotherapy Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Cell-Based Immunotherapy Revenue Market Share by Application (2017-2022) Table 30. Global Cell-Based Immunotherapy Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Cell-Based Immunotherapy Revenue Market Share by Application (2023-2028) Table 32. North America Cell-Based Immunotherapy Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Cell-Based Immunotherapy Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Cell-Based Immunotherapy Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Cell-Based Immunotherapy Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Cell-Based Immunotherapy Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Cell-Based Immunotherapy Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Cell-Based Immunotherapy Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Cell-Based Immunotherapy Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Cell-Based Immunotherapy Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Cell-Based Immunotherapy Market Size by Country (2023-2028) & (US$ Million) Table 42. Novartis Company Detail Table 43. Novartis Business Overview Table 44. Novartis Cell-Based Immunotherapy Product Table 45. Novartis Revenue in Cell-Based Immunotherapy Business (2017-2022) & (US$ Million) Table 46. Novartis Recent Development Table 47. Gilead Sciences Company Detail Table 48. Gilead Sciences Business Overview Table 49. Gilead Sciences Cell-Based Immunotherapy Product Table 50. Gilead Sciences Revenue in Cell-Based Immunotherapy Business (2017-2022) & (US$ Million) Table 51. Gilead Sciences Recent Development Table 52. AbbVie Company Detail Table 53. AbbVie Business Overview Table 54. AbbVie Cell-Based Immunotherapy Product Table 55. AbbVie Revenue in Cell-Based Immunotherapy Business (2017-2022) & (US$ Million) Table 56. AbbVie Recent Development Table 57. Bristol-Myers Squibb Company Detail Table 58. Bristol-Myers Squibb Business Overview Table 59. Bristol-Myers Squibb Cell-Based Immunotherapy Product Table 60. Bristol-Myers Squibb Revenue in Cell-Based Immunotherapy Business (2017-2022) & (US$ Million) Table 61. Bristol-Myers Squibb Recent Development Table 62. Amgen Company Detail Table 63. Amgen Business Overview Table 64. Amgen Cell-Based Immunotherapy Product Table 65. Amgen Revenue in Cell-Based Immunotherapy Business (2017-2022) & (US$ Million) Table 66. Amgen Recent Development Table 67. AstraZeneca Company Detail Table 68. AstraZeneca Business Overview Table 69. AstraZeneca Cell-Based Immunotherapy Product Table 70. AstraZeneca Revenue in Cell-Based Immunotherapy Business (2017-2022) & (US$ Million) Table 71. AstraZeneca Recent Development Table 72. Biogen Company Detail Table 73. Biogen Business Overview Table 74. Biogen Cell-Based Immunotherapy Product Table 75. Biogen Revenue in Cell-Based Immunotherapy Business (2017-2022) & (US$ Million) Table 76. Biogen Recent Development Table 77. Boehringer Ingelheim Company Detail Table 78. Boehringer Ingelheim Business Overview Table 79. Boehringer Ingelheim Cell-Based Immunotherapy Product Table 80. Boehringer Ingelheim Revenue in Cell-Based Immunotherapy Business (2017-2022) & (US$ Million) Table 81. Boehringer Ingelheim Recent Development Table 82. Eli Lilly and Company Company Detail Table 83. Eli Lilly and Company Business Overview Table 84. Eli Lilly and Company Cell-Based Immunotherapy Product Table 85. Eli Lilly and Company Revenue in Cell-Based Immunotherapy Business (2017-2022) & (US$ Million) Table 86. Eli Lilly and Company Recent Development Table 87. GSK Company Detail Table 88. GSK Business Overview Table 89. GSK Cell-Based Immunotherapy Product Table 90. GSK Revenue in Cell-Based Immunotherapy Business (2017-2022) & (US$ Million) Table 91. GSK Recent Development Table 92. Pfizer Company Detail Table 93. Pfizer Business Overview Table 94. Pfizer Cell-Based ImmunotherapyProduct Table 95. Pfizer Revenue in Cell-Based Immunotherapy Business (2017-2022) & (US$ Million) Table 96. Pfizer Recent Development Table 97. Roche Company Detail Table 98. Roche Business Overview Table 99. Roche Cell-Based ImmunotherapyProduct Table 100. Roche Revenue in Cell-Based Immunotherapy Business (2017-2022) & (US$ Million) Table 101. Roche Recent Development Table 102. Takara Bio Company Detail Table 103. Takara Bio Business Overview Table 104. Takara Bio Cell-Based ImmunotherapyProduct Table 105. Takara Bio Revenue in Cell-Based Immunotherapy Business (2017-2022) & (US$ Million) Table 106. Takara Bio Recent Development Table 107. Bausch Health Company Detail Table 108. Bausch Health Business Overview Table 109. Bausch Health Cell-Based ImmunotherapyProduct Table 110. Bausch Health Revenue in Cell-Based Immunotherapy Business (2017-2022) & (US$ Million) Table 111. Bausch Health Recent Development Table 112. Apac Biotech Company Detail Table 113. Apac Biotech Business Overview Table 114. Apac Biotech Cell-Based ImmunotherapyProduct Table 115. Apac Biotech Revenue in Cell-Based Immunotherapy Business (2017-2022) & (US$ Million) Table 116. Apac Biotech Recent Development Table 117. Dendreon Pharmaceuticals (SanPower) Company Detail Table 118. Dendreon Pharmaceuticals (SanPower) Business Overview Table 119. Dendreon Pharmaceuticals (SanPower) Cell-Based ImmunotherapyProduct Table 120. Dendreon Pharmaceuticals (SanPower) Revenue in Cell-Based Immunotherapy Business (2017-2022) & (US$ Million) Table 121. Dendreon Pharmaceuticals (SanPower) Recent Development Table 122. JW CreaGene Company Detail Table 123. JW CreaGene Business Overview Table 124. JW CreaGene Cell-Based ImmunotherapyProduct Table 125. JW CreaGene Revenue in Cell-Based Immunotherapy Business (2017-2022) & (US$ Million) Table 126. JW CreaGene Recent Development Table 127. Green Cross Corp Company Detail Table 128. Green Cross Corp Business Overview Table 129. Green Cross Corp Cell-Based ImmunotherapyProduct Table 130. Green Cross Corp Revenue in Cell-Based Immunotherapy Business (2017-2022) & (US$ Million) Table 131. Green Cross Corp Recent Development Table 132. Research Programs/Design for This Report Table 133. Key Data Information from Secondary Sources Table 134. Key Data Information from Primary Sources List of Figures Figure 1. Global Cell-Based Immunotherapy Market Share by Type: 2021 VS 2028 Figure 2. Autologous Cellular Immunotherapy Features Figure 3. Chimeric Antigen Receptor (CAR) T-Cell Therapy Features Figure 4. Dendritic Cell-based Vaccine Therapy Features Figure 5. Global Cell-Based Immunotherapy Market Share by Application in 2021 & 2028 Figure 6. Hospitals Case Studies Figure 7. Clinics Case Studies Figure 8. Ambulatory Surgical Centers Case Studies Figure 9. Others Case Studies Figure 10. Cell-Based Immunotherapy Report Years Considered Figure 11. Global Cell-Based Immunotherapy Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Cell-Based Immunotherapy Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Cell-Based Immunotherapy Market Share by Region: 2021 VS 2028 Figure 14. Global Cell-Based Immunotherapy Market Share by Players in 2021 Figure 15. Global Top Cell-Based Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Based Immunotherapy as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Cell-Based Immunotherapy Revenue in 2021 Figure 17. North America Cell-Based Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. North America Cell-Based Immunotherapy Market Share by Country (2017-2028) Figure 19. United States Cell-Based Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Canada Cell-Based Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Cell-Based Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Cell-Based Immunotherapy Market Share by Country (2017-2028) Figure 23. Germany Cell-Based Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. France Cell-Based Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. U.K. Cell-Based Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Italy Cell-Based Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Russia Cell-Based Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Nordic Countries Cell-Based Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Cell-Based Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Cell-Based Immunotherapy Market Share by Region (2017-2028) Figure 31. China Cell-Based Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Japan Cell-Based Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. South Korea Cell-Based Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Southeast Asia Cell-Based Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. India Cell-Based Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Australia Cell-Based Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Cell-Based Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Cell-Based Immunotherapy Market Share by Country (2017-2028) Figure 39. Mexico Cell-Based Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Brazil Cell-Based Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Cell-Based Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Cell-Based Immunotherapy Market Share by Country (2017-2028) Figure 43. Turkey Cell-Based Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Saudi Arabia Cell-Based Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Novartis Revenue Growth Rate in Cell-Based Immunotherapy Business (2017-2022) Figure 46. Gilead Sciences Revenue Growth Rate in Cell-Based Immunotherapy Business (2017-2022) Figure 47. AbbVie Revenue Growth Rate in Cell-Based Immunotherapy Business (2017-2022) Figure 48. Bristol-Myers Squibb Revenue Growth Rate in Cell-Based Immunotherapy Business (2017-2022) Figure 49. Amgen Revenue Growth Rate in Cell-Based Immunotherapy Business (2017-2022) Figure 50. AstraZeneca Revenue Growth Rate in Cell-Based Immunotherapy Business (2017-2022) Figure 51. Biogen Revenue Growth Rate in Cell-Based Immunotherapy Business (2017-2022) Figure 52. Boehringer Ingelheim Revenue Growth Rate in Cell-Based Immunotherapy Business (2017-2022) Figure 53. Eli Lilly and Company Revenue Growth Rate in Cell-Based Immunotherapy Business (2017-2022) Figure 54. GSK Revenue Growth Rate in Cell-Based Immunotherapy Business (2017-2022) Figure 55. Pfizer Revenue Growth Rate in Cell-Based Immunotherapy Business (2017-2022) Figure 56. Roche Revenue Growth Rate in Cell-Based Immunotherapy Business (2017-2022) Figure 57. Takara Bio Revenue Growth Rate in Cell-Based Immunotherapy Business (2017-2022) Figure 58. Bausch Health Revenue Growth Rate in Cell-Based Immunotherapy Business (2017-2022) Figure 59. Apac Biotech Revenue Growth Rate in Cell-Based Immunotherapy Business (2017-2022) Figure 60. Dendreon Pharmaceuticals (SanPower) Revenue Growth Rate in Cell-Based Immunotherapy Business (2017-2022) Figure 61. JW CreaGene Revenue Growth Rate in Cell-Based Immunotherapy Business (2017-2022) Figure 62. Green Cross Corp Revenue Growth Rate in Cell-Based Immunotherapy Business (2017-2022) Figure 63. Bottom-up and Top-down Approaches for This Report Figure 64. Data Triangulation Figure 65. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research

Can't find what you're looking for about this report?

Submit Query

Go to contact form

Phone Number

1-302-273-0910
Chat with us